Mireille Kamariza, PhD
Mireille Kamariza is a junior fellow at the Society of Fellows at Harvard University. With a background in infectious disease research, she examines topics regarding the future of precision medicine in global health.
Prior to her appointment at Harvard, she completed her doctoral studies in biology at Stanford University where she developed a new diagnostic technology for the rapid and simple detection of tuberculosis at the point-of-care. Her work was translated into a public benefit corporation and, as a co-founder of OliLux Biosciences, Inc.—a company dedicated to providing low-cost, portable, and reliable diagnostic devices in low-resource settings—she continues to serve underserved and underrepresented populations. Kamariza also holds a master’s degree from UC Berkeley in molecular and cell biology, and a bachelor’s degree from the UC San Diego, in biochemistry and chemistry.
Hosted by: Seth Shipman, PhD
The Convergence Seminar is organized by Gladstone’s Institute for Data Science and Biotechnology. This seminar series brings together scientists from varying disciplines to solve complex scientific questions and accelerate the path to cures.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.